Scarica l'app Stockscreener
15.27
0.86%
0.13
Dopo l'orario di chiusura:
15.14
-0.13
-0.85%
Precedente Chiudi:
$15.14
Aprire:
$15.15
Volume 24 ore:
76,045
Relative Volume:
1.01
Capitalizzazione di mercato:
$189.85M
Reddito:
-
Utile/perdita netta:
$-31.48M
Rapporto P/E:
-14.68
EPS:
-1.04
Flusso di cassa netto:
$-28.71M
1 W Prestazione:
-1.42%
1M Prestazione:
+40.22%
6M Prestazione:
+159.25%
1 anno Prestazione:
+217.46%
Intervallo 1D:
$14.50
$15.27
Intervallo di 1 settimana:
$13.76
$15.30
Portata 52W:
$4.11
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
Nome
Forte Biosciences Inc
Settore
Industria
Telefono
(310) 618-6994
Indirizzo
3060 PEGASUS PARK DRIVE, DALLAS, CA
Confronta FBRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
15.27 | 188.23M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Iniziato | Guggenheim | Buy |
| 2025-01-21 | Iniziato | TD Cowen | Buy |
| 2024-04-08 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Aggiornamento | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Downgrade | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Downgrade | Truist | Buy → Hold |
| 2021-05-14 | Iniziato | B. Riley Securities | Buy |
| 2021-03-26 | Iniziato | Citigroup | Buy |
| 2020-08-28 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Iniziato | Truist | Buy |
Mostra tutto
Forte Biosciences Inc Borsa (FBRX) Ultime notizie
Forecasting Forte Biosciences Inc. price range with options data2025 Support & Resistance & Safe Entry Zone Tips - newser.com
What institutional flow reveals about Forte Biosciences Inc.GDP Growth & Daily Entry Point Trade Alerts - newser.com
Is Forte Biosciences Inc. stock entering bullish territoryPortfolio Profit Report & Fast Gain Swing Alerts - newser.com
How to read the order book for Forte Biosciences Inc.Trade Risk Summary & Community Shared Stock Ideas - newser.com
Forte Biosciences Inc. stock prediction for this weekGap Down & Comprehensive Market Scan Reports - newser.com
Chart based analysis of Forte Biosciences Inc. trendsOil Prices & AI Driven Price Forecasts - newser.com
What makes Forte Biosciences Inc. (37T) stock appealing to growth investors2025 Market Trends & Real-Time Buy Zone Alerts - newser.com
Why Forte Biosciences Inc. stock is a value investor pickQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
Is Forte Biosciences Inc. building a consolidation baseInsider Selling & Daily Chart Pattern Signal Reports - newser.com
Forte Biosciences (NASDAQ:FBRX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Forte Biosciences Inc. Reports Inducement Grants Under Nasdaq Listing Rules - MarketScreener
Can a trend reversal in Forte Biosciences Inc. lead to recoveryTrend Reversal & Weekly High Conviction Ideas - newser.com
Will Forte Biosciences Inc. continue its uptrendDollar Strength & Fast Moving Stock Trade Plans - newser.com
Forte Biosciences reports inducement grants under Nasdaq listing rules - MarketScreener
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - MarketScreener
Will Forte Biosciences Inc. (37T) stock outperform Dow JonesTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat
How to build a dashboard for Forte Biosciences Inc. stock2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Forte Biosciences (FBRX) Price Target Increased by 16.98% to 53.30 - Nasdaq
What to do if you’re stuck in Forte Biosciences Inc.2025 Institutional Moves & Long Hold Capital Preservation Plans - newser.com
Can ACE Edutrend Limited Maintain Its Growth Rate as a Small CapPrice Volatility Patterns & 100% Free Stock Analysis for Smarter Decisions - earlytimes.in
Forte Biosciences Inc Azioni (FBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Forte Biosciences Inc Azioni (FBRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wagner Paul A. | SEE REMARKS |
Oct 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
82,190 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,733 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
81,038 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,372 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,151 |
| Wagner Paul A. | SEE REMARKS |
Jan 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
78,720 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Nov 21 '24 |
Buy |
5.55 |
22,514 |
124,998 |
30,776 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):